Cutting Edge Commerical Products to Spur Growth in US Soft Tissue Repair Market Over Coming Years

According to MRG’s new report, US Markets for Soft Tissue 2006, the US market for soft tissue repair will grow by over $500 million over the next 5 years, reaching annual sales of over $1 billion in 2010.

(PRWEB) July 17, 2006

Waltham, Massachusetts—Millennium Research Group (MRG), the global authority on medical technology market intelligence, reports that approximately 2 million soft tissue procedures, comprising hernia repair, vaginal sling implantation, dural repair, pelvic floor reconstruction, staple line reinforcement, and cardiovascular patching, are performed annually in the US, making these procedures some of the most commonly performed surgeries in the country. Of these procedures, more than three-quarters were performed using a commercial patch, mesh, or sling-like biomaterial. According to MRG’s new report, US Markets for Soft Tissue 2006, the US market for soft tissue repair will grow by over $500 million over the next 5 years, reaching annual sales of over $1 billion in 2010.

The US market for soft tissue repair comprises procedures that repair hernias, treat incontinence, repair the outer cranial and spinal tissue, treat pelvic floor defects, and reinforce staple lines that result from surgical incisions. Other surgical procedures that incorporate soft tissue repair are additionally rising in the US, contributing to growth in demand for commercial soft tissue repair products. For example, gastric bypass procedures continue to increase in conjunction with the national epidemic of obesity in the US. US surgeons are acknowledging the benefits of soft tissue materials in treating the aging population, and technological innovation is further driving physician adoption. By 2010, almost 2 million procedures using a soft tissue commercial product will be performed annually in the US.

The emergence of new technologies and materials that offer patients faster recovery after surgery is a leading driver in the US market for soft tissue. For example, synthetic materials coated in animal collagen increase biocompatibility with the body and reduce inflammation and discomfort. Additionally, soft tissue mesh materials are increasingly used to prevent excess bleeding and avoid postsurgery complications.

MRG’s US Markets for Soft Tissue 2006 report is part of the Global Markets for Soft Tissue series, which also includes analysis on Europe. The global report series covers over 40 competitors, including C.R. Bard (BCR), Ethicon (JNJ), LifeCell (LIFC), W.L. Gore, Gynecare (JNJ), and American Medical Systems (AMMD).

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

###